期刊文献+

肿瘤转移抑制因子CD9/MRP-1基因在小鼠围着床期子宫内膜的动态表达 被引量:4

Spatiotemporal Expression of Tumor Metastasis Inhibitory Factor CD9/MRP-1 Gene in Mouse Endometrium during Embryo Pre-implantation
下载PDF
导出
摘要 目的:探讨肿瘤转移抑制基因(CD9)/运动相关蛋白(MRP-1)mRNA和蛋白在胚胎着床过程中的作用。方法:应用RT-PCR和免疫组化技术观察CD9/MRP-1mRNA和蛋白在早孕和假孕小鼠子宫中的表达规律。结果:早孕d1-4小鼠子宫组织均有CD9/MRP-1mRNA表达,且d4表达最多;其蛋白主要表达在d1-4的子宫内膜上皮细胞,且早孕d2-4CD9/MRP-1在子宫基质细胞散在阳性表达。假孕d1-8小鼠子宫组织均有CD9/MRP-1mRNA表达,假孕d5表达开始增加,至d6达到峰值。而CD9/MRP-1蛋白在假孕d1-8子宫内膜腺上皮均有表达,而子宫内膜腔上皮均无表达。假孕d2-5,子宫基质细胞出现散在阳性表达。结论:①CD9/MRP-1在早孕小鼠子宫中呈动态表达,提示它在胚胎精确侵袭子宫内膜的调节中发挥作用。②CD9/MRP-1在妊娠小鼠子宫的表达是非胚胎依赖性的。 Objective: To explore effects during the process of embryonic implantation. Methods: Protein and mRNA expression of tumor metastasis suppressor gene CD9/MRP- 1 were detected by immunohistochemistry and RT-PCR in mouse uterus during early pregnancy and pseudopregnancy. Results: In the mouse uterus during pregnancy d 1-4, CD9/MRP-1 mRNA was expressed and it was dramatically abundant on d 4. CD9/MRP- 1 protein was expressed mainly in epithelial cells, dispersively positive expression was observed in stromal ceils during pregnancy d 2-4. In the uterus during pseudopregnancy d 1-8, CD9/MRP-1 mRNA was expressed and gradually increased from d 5, it was dramatically abundant on d 6. CD9/MRP-1 protein was expressed mainly in glandular epithelial cells, dispersively positive expression was observed in stromal cells during d 2-5, however, no expression was detected in luminal epithelial ceils during d 1-8 of pseudopregnancy. Conclusions: 1) Spatiotemporal expression of CD9/MRP-1 in mouse uterus showed that it might play roles in regulating precise invasion of embryo into uterine endometrium. 2) Expression of CD9/MRP-1 in uterus was independent of existence of embryos in pregnant mice.
出处 《生殖与避孕》 CAS CSCD 北大核心 2008年第9期513-518,共6页 Reproduction and Contraception
基金 国家自然科学基金项目(项目号:30470654)
关键词 肿瘤转移抑制因子(CD9)/运动相关蛋白(MRP-1) 子宫内膜 胚胎着床 CD9/MRP-1 uterine endometrium embryo implantation
  • 相关文献

参考文献5

二级参考文献58

  • 1Uzawa K, Ono K, Suzuki H, Tanaka C, Yakushiji T, Yamamoto N, Yokoe H, Tanzawa H. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.Clin Cancer Res 2002; 8:828-835.
  • 2Geradts J, Maynard R, Birrer MJ, Hendricks D, Abbondanzo SL,Fong KM, Barrett JC, Lombardi DP. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. Am J Pathol 1999; 154:1665-1671.
  • 3Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995; 268:884-886.
  • 4Dong Jr, Isaacs WB, Barrett JC, Isaacs JT. Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics 1997;41:25-32.
  • 5Petty HR, W.orth RG, Todd R F 3rd. Interactions of integrins with their partner proteins in leukocyte membranes. Immunol Res 2002;25:75-95.
  • 6Maecker HT, Todd SC, Levy S. The tetraspanin superfamily:molecular facilitators. FASEB J 1997; 11:428-442.
  • 7White A, Lamb PW, Barrett JC. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines. Oncogene 1998; 16:3143-3149.
  • 8Okochi H_Mine T, Nashiro K, Suzuki J, Fujita T, Furue M. Expression of tetraspans transmembrane family in the epithelium of the gastrointestinal tract. J Clin Gastroenterol 1999: 29:63-67.
  • 9Adachi M, Taki T, Konishi T, Huang CI, Higashiyama M, Miyake M. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. J Clin Oncol 1998; 16:1397-1406.
  • 10Rubinstein E, Le Naour F, Lagaudriere C, esbert C, Billard M,Conjeaud H, Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 1996; 26:2657-2665.

共引文献25

同被引文献41

  • 1赵邦霞,谭冬梅,何明忠,陈媛,高立芳,谭毅.肿瘤转移抑制因子CD63/ME491基因在小鼠子宫内膜表达的动态观察[J].第三军医大学学报,2007,29(10):885-888. 被引量:5
  • 2Zoller M. Tetraspanins : push and pull in suppressing and promoting metastasis[ J]. Nat Rev Cancer,2009,9( 1 ) :40-55.
  • 3Miyake M, Inufusa H, Adachi M, et al. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/ CD9 ) gene delivery [ J ]. Oncogene,2000,19 (46) : 5221-5226.
  • 4Arroyo M M, Mayo K H. Relevance to cancer[ J]. Biochim Biophys Acta,1996(128) :61- 67.
  • 5Rubinstein E,Naour F L, Billard M,et al. CD9 antigens an accessory subunit of the VLA integrin complexes [ J ]. Eur J Immunol, 1994,24(12) :3005-3013.
  • 6Erovic B M, Pammer J, Hollemann D, et al. Motility-related protein-1 CD9 expression in head and neck squamous cell carcinoma[J]. Head Neck,2003,25 (10) :848-857.
  • 7Tachibana I, Martin E, Hemler R. Transmembr supertamily (TM4SF) proteins CD9 and CD81 in musele cell fusion and myotube maintenance [ J ]. J Cell Biol, 1999,146 ( 4 ) : 893-904.
  • 8Furuya M,Kato H, Nishimura N, et al. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination:morphologic alteration and reduced expression of betal integrin subsets [ J]. Cancer Res ,2005,65 ( 7 ) : 2617-2625.
  • 9Williams A A, Higgins J P T, Zhao H, et al. CD9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma [ J ]. BMC Clin Pathol,2009 ,9 (9) :1-11.
  • 10Nakazawa Y, Sato S, Naito M, et al. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis [ J ]. Blood, 2008, 112 ( 5 ) : 1730-1739.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部